Developing a Test to Detect Aggressive Prostate Cancer

Dr. Fred Saad

Prostate cancer tends to be a slow growing disease and some men can safely take advantage of active surveillance instead of going under the knife or having radiation. However, some cases are aggressive and should be treated with surgery or radiation right away.

Dr. Saad’s research is aimed at identifying these cases. He has found significant links between a group of proteins, called nuclear factor-kappa B (NFKB), and prostate cancer. In surgically removed prostates, he found that NFKB’s presence heralded a host of negative outcomes including: metastasis to the lymph nodes and bones and PSA relapse. With further research, he hopes to show that that testing NFKB levels during biopsy will pinpoint patients at risk of aggressive prostate cancer and help personalize therapy.

Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More


Click here for news archive